Finance

Lists
003020:SHE
Hefei Lifeon Pharmaceutical Co Ltd
CNÂ¥17.89
+0.96%
(+0.17) 1D
Sep 8, 3:04:54 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 003020...
Open
CNÂ¥17.72
High
CNÂ¥17.98
Low
CNÂ¥17.60
Mkt. cap
4.04B
Avg. vol.
10.69M
Volume
2.93M
Dividend
2.33%
Quarterly dividend
CNÂ¥0.10
Ex-dividend date
May 29, 2026
P/E ratio
25.00
52-wk high
CNÂ¥27.11
52-wk low
CNÂ¥14.20
EPS
CNÂ¥0.72
Shares outstanding
228.22M
No. of employees
1K
Open
CNÂ¥17.72
High
CNÂ¥17.98
Low
CNÂ¥17.60
Mkt. cap
4.04B
Avg. vol.
10.69M
Volume
2.93M
Dividend
2.33%
Quarterly dividend
CNÂ¥0.10
Ex-dividend date
May 29, 2026
P/E ratio
25.00
52-wk high
CNÂ¥27.11
52-wk low
CNÂ¥14.20
EPS
CNÂ¥0.72
Shares outstanding
228.22M
No. of employees
1K
About Hefei Lifeon Pharmaceutical Co Ltd
CEO-
Employees1.46K
FoundedJul 16, 2002
Headquarters-
SectorPharmaceutical industry
Websitelifeon.cn
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
348.25M
473.12M
357.10M
327.16M
Cost of goods sold
112.98M
179.98M
121.91M
107.73M
Cost of revenue
112.98M
179.98M
121.91M
107.73M
Research and development expenses
19.45M
39.36M
18.38M
24.76M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
171.75M
215.72M
170.83M
137.46M
Operating expense
195.72M
262.92M
193.88M
163.71M
Total operating expenses
308.69M
442.90M
315.80M
271.45M
Operating income
39.55M
30.22M
41.30M
55.72M
Other non operating income
-544.58K
604.09K
-537.41K
-2.03M
EBT including unusual items
35.98M
44.93M
41.31M
54.17M
EBT excluding unusual items
40.71M
30.20M
40.63M
56.87M
Income tax expense
4.40M
4.49M
6.05M
4.34M
Effective tax rate
12.23%
10.00%
14.65%
8.01%
Other operating expenses
5.15M
7.85M
4.63M
1.53M
Net income
30.71M
44.25M
35.29M
52.91M
Net profit margin
8.82%
9.35%
9.88%
16.17%
Earnings per share
-
-
-
-
Interest and investment income
1.69M
692.37K
264.54K
3.18M
Interest expense
-
-1.26M
-399.14K
-
Net interest expenses
1.69M
-564.11K
-134.59K
3.18M
Depreciation and amortization charges
-
-
-
-
EBITDA
58.28M
51.18M
62.27M
78.14M
Gain or loss from assets sale
1.77K
1.68K
-
-49.79K
AI content may include mistakes. Learn more
Google apps